Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MK-3102
MK-3102
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Fierce Biotech
Thu, 09/18/14 - 09:24 am
Merck
diabetes
Januvia
omarigliptin
MK-3102
Extending the Diabetes Dominance
Motley Fool
Sat, 10/6/12 - 11:49 am
Merck
MK-3102
Januvia
diabetes
type 2 diabetes
Merck's once-a-week diabetes drug effective in clinical study
Reuters
Wed, 10/3/12 - 11:21 am
Merck
diabetes
MK-3102